SpringerLink
Log in

Strabismus in Thyroid-Associated Orbitopathy

  • Chapter
  • First Online:
Oculoplastic, Lacrimal and Orbital Surgery

  • 145 Accesses

Abstract

Thyroid associated orbitopathy (TAO) is a frequent cause of single or multiple extraocular muscle enlargement leading to restrictive strabismus. The impairment of ocular motility is caused by inflammation, followed by fibrosis, of the muscles involved. The inferior rectus and medial rectus muscles are most commonly involved, with typical enlargement of the muscle belly and sparing of the muscle tendon. Pathophysiology of TAO involves insulin-like growth factor-1 receptor (IGF-1R) overexpression and activation, with increased release of proinflammatory cytokines, inflammation, and expansion of extraocular muscle and consequent restrictive strabismus. Glucocorticoids are the first-line treatment of active TAO to reduce orbital inflammation to improve extraocular motility, and to reduce diplopia. Orbital radiation therapy (OR) is effective in recent onset ocular motility impairment. Teprotumumab, an insulin-like growth factor-1 receptor inhibitor, has shown remarkable results in reduction of diplopia in multicenter, randomized placebo-controlled trials. In patients with TAO, strabismus surgery should not be carried out until the angle of deviation is stable for at least 4 months, and observation is advisable when diplopia is absent in primary or reading position. Indications, timing and aims of surgical treatment and basic rules of surgical techniques are described and discussed. Under-correction is the most common reported complication of horizontal strabismus correction; late over-correction may occur following inferior rectus recession. Strabismus surgery should be performed after decompression surgery, as decompression can modify the initial deviation or result in new onset strabismus. However, a combined surgical treatment may be proposed in selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Savino G, Petrone G, Volpe G, Midena G, Grimaldi G, Fiorentino V, Maceroni M. Vertical restrictive strabismus associated with proptosis: Similar clinical signs, different etiopathogenetic causes. A report of three patients. Eur J Ophthalmol. 2020:1120672120946929.

    Google Scholar 

  2. Garrity J, Bahn R. Pathogenesis of Graves ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol. 2006;142:147–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Bahn RS. Current insights into the pathogenesis of Graves’ ophthalmopathy. Horm Metab Res. 2015;47:773–8.

    Article  CAS  PubMed  Google Scholar 

  4. Schotthoefer EO, Wallace DK. Strabismus associated with thyroid eye disease. Curr Opin Ophthalmol. 2007;18:361–5.

    Article  PubMed  Google Scholar 

  5. Van der Gaag R, Vernimmen R, Fiebelkorn N, et al. Graves’ophthalmopathy: what is the evidence for extraocular muscle specific autoantibodies. Int Ophthalmol. 1990;14:25–30.

    Article  PubMed  Google Scholar 

  6. Sergott RC, Glaser JS. Graves’ ophhalmopathy. A clinical and immunologic review. Surv Ophthalmol. 1981;26:1–21.

    Article  CAS  PubMed  Google Scholar 

  7. Wang Y, Mettu P, Broadbent T, Radke P, Kevin Firl J, Banks Shepherd III, Couch SM, Nguyen A, Henderson AD, McCulley T, McClelland CM, Mokhtarzadeh A, Lee MS, Garrity JA, Harrison AR. Thyroid eye disease presenting with superior rectus/levator complex enlargement. Orbit. 2020;39:5–12.

    Google Scholar 

  8. Lee CE, Choi SH, Yoon JS. Chemokine expression during adipogenesis and inflammation in orbital fibroblasts from patients with Graves’ orbitopathy. Korean J Ophthalmol. 2020;34:192–202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Li H, Ma C, Liu W, He J, Li K. Gypenosides protect orbital fibroblasts in Graves ophthalmopathy via anti-inflammation and anti-fibrosis effects. Invest Ophthalmol Vis Sci. 2020;61:64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Douglas RS, Gianoukakis AG, Kamat S, Smith TJ. Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves’ disease may carry functional consequences for disease pathogenesis. J Immunol. 2007;178:3281–7.

    Article  CAS  PubMed  Google Scholar 

  11. Douglas RS. Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis. Eye (Lond). 2019;33:183–90.

    Article  CAS  PubMed  Google Scholar 

  12. Douglas RS, Kahaly GJ, Patel A, Sile S, Thompson EHZ, Perdok R, Fleming JC, Fowler BT, Marcocci C, Marinò M, Antonelli A, Dailey R, Harris GJ, Eckstein A, Schiffman J, Tang R, Nelson C, Salvi M, Wester S, Sherman JW, Vescio T, Holt RJ, Smith TJ. Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med. 2020;382:341–52.

    Article  CAS  PubMed  Google Scholar 

  13. Papp A, Lawson JM, Calder V, Fells P, Lightman S. T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy. Br J Ophthalmol. 2000;84:517–22.

    Article  Google Scholar 

  14. Akbari MR, Mirmohammadsadeghi A, Mahmoudzadeh R, Veisi A. Management of thyroid eye disease-related strabismus. J Curr Ophthalmol. 2020;32:1–13.

    PubMed  PubMed Central  Google Scholar 

  15. Harrad R. Management of strabismus in thyroid eye disease. Eye (Lond). 2015;29:234–7.

    Article  CAS  PubMed  Google Scholar 

  16. Jefferis JM, Raoof N, Burke JP. Prioritising downgaze alignment in the management of vertical strabismus for thyroid eye disease: principles and outcomes. Eye (Lond). 2020;34:906–14.

    Article  CAS  PubMed  Google Scholar 

  17. Akbari M, Bayat R, Mirmohammadsadeghi A, Mahmoudzadeh R, Eshraghi B, Salabati M. Strabismus surgery in thyroid-associated ophthalmopathy; surgical outcomes and surgical dose responses. J Binocul Vis Ocul Motil. 2020;70:150–6.

    Article  PubMed  Google Scholar 

  18. Matlach J, Döllinger VKR, Eha J, Elflein HM, Weyer-Elberich V, Mildenberger P, Pitz S. Ocular ductions after rectus muscle recession and resection in thyroid eye disease. Strabismus. 2019;27:143–8.

    Article  PubMed  Google Scholar 

  19. Roper-Hall G. Evaluation of the field of binocular single vision in incomitant strabismus. Am J Ophthalmol. 1974;78:800–5.

    Article  PubMed  Google Scholar 

  20. Lo C, Ugradar S, Rootman D. Management of Graves myopathy: Orbital imaging in thyroid-related orbitopathy. J AAPOS. 2018;22:256.e1–9.

    Article  PubMed  Google Scholar 

  21. Politi LS, Godi C, Cammarata G, Ambrosi A, Iadanza A, Lanzi R, et al. Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg. Eur Radiol. 2014;24:1118–26.

    Article  PubMed  Google Scholar 

  22. Kirsch EC, Kaim AH, De Oliveira MG, von Arx G. Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves’ orbitopathy—a pilot study at 1.5 T. Neuroradiology. 2010;52:91–7.

    Article  PubMed  Google Scholar 

  23. Bartalena L, Baldeschi L, Boboridis K, et al. The 2016 European Thyroid Association/European group on Graves’ orbitopathy guidelines for the management of Graves’ orbitopathy. Eur Thyroid J. 2016;5:9–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Bartalena L, Krassas GE, Wiersinga W, et al. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves’ orbitopathy. J Clin Endocrinol Metab. 2012;97:4454–63.

    Article  CAS  PubMed  Google Scholar 

  25. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell’Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves’ ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab. 2001;86:3562–7.

    CAS  PubMed  Google Scholar 

  26. Zang S, Ponto KA, Kahaly GJ. Clinical review: Intravenous glucocorticoids for Graves’ orbitopathy: efficacy and morbidity. J Clin Endocrinol Metab. 2011;96:320–32.

    Article  CAS  PubMed  Google Scholar 

  27. Minakaran N, Ezra DG. Rituximab for thyroid-associated ophthalmopathy. Cochrane Database Syst Rev. 2013;5:CD009226.

    Google Scholar 

  28. Hamed Azzam S, Kang S, Salvi M, Ezra DG. Tocilizumab for thyroid eye disease. Cochrane Database Syst Rev. 2018;11:CD012984.

    PubMed  Google Scholar 

  29. Douglas RS, Gupta S. The pathophysiology of thyroid eye disease: implications for immunotherapy. Curr Opin Ophthalmol. 2011;22:385–90.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Le Moli R, Baldeschi L, Saeed P, Regensburg N, Mourits MP, Wiersinga WM. Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves’ ophthalmopathy. Thyroid. 2007;17:357–62.

    Article  PubMed  Google Scholar 

  31. Ebner R, Devoto MH, Weil D, et al. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol. 2004;88:1380–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Bartalena L, Pinchera A, Marcocci C. Management of Graves’ophthalmopathy: reality and perspectives. Endocr Rev. 2000;21:168–99.

    CAS  PubMed  Google Scholar 

  33. Tanda ML, Bartalena L. Efficacy and safety of orbital radiotherapy for Graves’ orbitopathy. J Clin Endocrinol Metab. 2012;97:3857–65.

    Article  CAS  PubMed  Google Scholar 

  34. Kahaly G, Beyer J. Immunosuppressant therapy of thyroid eye disease. Klin Wochenschr. 1988;66:1049–59.

    Article  CAS  PubMed  Google Scholar 

  35. Mourits MP, van Kempen-Harteveld ML, García MB, Koppeschaar HP, Tick L, Terwee CB. Radiotherapy for Graves’ orbitopathy: randomised placebo-controlled study. Lancet. 2000;355:1505–9.

    Article  CAS  PubMed  Google Scholar 

  36. Prummel MF, Terwee CB, Gerding MN, et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves’ ophthalmopathy. J Clin Endocrinol Metab. 2004;89:15–20.

    Article  CAS  PubMed  Google Scholar 

  37. Oeverhaus M, Witteler T, Lax H, et al. Combination therapy of intravenous steroids and orbital irradiation is more effective than intravenous steroids alone in patients with Gravesʼ orbitopathy. Horm Metab Res. 2017;49:739–47.

    Article  CAS  PubMed  Google Scholar 

  38. Kim JW, Lee KH, Woo YJ, Kim J, Keum KC, Yoon JS. The effect of systemic steroids and orbital radiation for active Graves orbitopathy on postdecompression extraocular muscle volume. Am J Ophthalmol. 2016;171:11–7.

    Article  CAS  PubMed  Google Scholar 

  39. Bartalena L, Marcocci C, Chiovato L, et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves’ ophthalmopathy: comparison with systemic corticosteroids alone. J Clin Endocrinol Metab. 1983;56:1139–44.

    Article  CAS  PubMed  Google Scholar 

  40. Ng CM, Yuen HK, Choi KL, et al. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves’ ophthalmopathy: a preliminary study. Hong Kong Med J. 2005;11:322–30.

    CAS  PubMed  Google Scholar 

  41. Prummel MF, Mourits MP, Blank L, Berghout A, Koornneef L, Wiersinga WM. Randomized double-blind trial of prednisone versus radiotherapy in Graves’ ophthalmopathy. Lancet. 1993;342:949–54.

    Article  CAS  PubMed  Google Scholar 

  42. Sobel RK, Aakalu VK, Vagefi MR, Foster JA, Tao JP, Freitag SK, Wladis EJ, McCulley TJ, Yen MT. Orbital radiation for thyroid eye disease: A Report by the American Academy of Ophthalmology. Ophthalmology. 2022;129:450–5.

    Article  PubMed  Google Scholar 

  43. Pérez-Moreiras JV, Alvarez-López A, Gómez EC. Treatment of active corticosteroid-resistant Graves’ orbitopathy. Ophthalmic Plast Reconstr Surg. 2014;30:162–7.

    Article  PubMed  Google Scholar 

  44. Perez-Moreiras JV, Gomez-Reino JJ, Maneiro JR, et al. Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant Graves orbitopathy: a randomized clinical trial. Am J Ophthalmol. 2018;195:181–90.

    Article  CAS  PubMed  Google Scholar 

  45. Ayabe R, Rootman DB, Hwang CJ, Ben-Artzi A, Goldberg R. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2014;30:415–9.

    Article  PubMed  Google Scholar 

  46. Durrani OM, Reuser TQ, Murray PI. Infliximab: a novel treatment for sight-threatening thyroid associated ophthalmopathy. Orbit. 2005;24:117–9.

    Article  CAS  PubMed  Google Scholar 

  47. Wang Y, Patel A, Douglas RS. Thyroid eye disease: How a novel therapy may change the treatment paradigm. Ther Clin Risk Manage. 2019;15:1305–18.

    Article  CAS  Google Scholar 

  48. Krieger CC, Neumann S, Place RF, Marcus-Samuels B, Gershengorn MC. Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves’ disease immunoglobins. J Clin Endocrinol Metab. 2015;100:1071–7.

    Article  CAS  PubMed  Google Scholar 

  49. Chen H, Mester T, Raychaudhuri N, et al. Teprotumumab, an IGF1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. J Clin Endocrinol Metab. 2014;99:E1635–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Jain AP, Gellada N, Ugradar S, Kumar A, Kahaly G, Douglas R. Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease. Br J Ophthalmol. 2022;106:165–71.

    Article  PubMed  Google Scholar 

  51. Douglas RS, Kahaly GJ, Patel A, et al. Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med. 2020;382:341–52.

    Article  CAS  PubMed  Google Scholar 

  52. Skov C, Mazow M. Managing strabismus in endocrine eye disease. Can J Ophthalmol. 1984;19:269–74.

    CAS  PubMed  Google Scholar 

  53. Yeatts RP. Quality of life in patients with Graves ophthalmopathy. Trans Am Ophthalmol Soc. 2005;103:368–411.

    PubMed  PubMed Central  Google Scholar 

  54. Gunton KB. Prism use in adult diplopia. Curr Opin Ophthalmol 2012; 23:400e404.

    Google Scholar 

  55. Dunn WJ, Arnold AC, O’Connor PS. Botolinum toxin for the treatment of dysthyroid ocular myopathy. Ophthalmology. 1986;93:470–5.

    Article  CAS  PubMed  Google Scholar 

  56. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87:1044–9.

    Article  CAS  PubMed  Google Scholar 

  57. Lyons C, Vickers S, Lee J. Botulinum toxin therapy in dysthyroid strabismus. Eye. 1990;4:538–42.

    Article  PubMed  Google Scholar 

  58. Granet DB, Hodgson N, Godfrey KJ, et al. Chemodenervation of extraocular muscles with botulinum toxin in thyroid eye disease. Graefes Arch Clin Exp Ophthalmol. 2016;254:999e1.

    Article  Google Scholar 

  59. Gair EJ, Lee JP, Khoo BK, Maurino V. What is the role of botulinum toxin in the treatment of dysthyroid strabismus? J AAPOS. 1999;3:272–4.

    Article  CAS  PubMed  Google Scholar 

  60. Lyons CJ, Vickers SF, Lee JP. Botulinum toxin therapy in dysthyroid strabismus. Eye (Lond). 1990;4:538–42.

    Article  PubMed  Google Scholar 

  61. Kikkawa DO, Cruz RC Jr, Christian WK, et al. Botulinum A toxin injection for restrictive myopathy of thyroid-related orbitopathy: effects on intraocular pressure. Am J Ophthalmol. 2003;135:427–31.

    Article  CAS  PubMed  Google Scholar 

  62. Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA, et al. The treatment of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121:200–6.

    Article  CAS  PubMed  Google Scholar 

  63. Rajendram R, Bunce C, Adams GG, Dayan CM, Rose GE. Smoking and strabismus surgery in patients with thyroid eye disease. Ophthalmology. 2011;118:2493–7.

    Article  PubMed  Google Scholar 

  64. Jellema HM, Saeed P, Mombaerts I, Dolman PJ, Garrity J, Kazim M, et al. Objective and subjective outcomes of strabismus surgery in Graves’ orbitopathy: A prospective multicentre study. Acta Ophthalmol. 2017;95:386–91.

    Article  PubMed  Google Scholar 

  65. Volpe NJ, Mirza-George N, Binenbaum G. Surgical management of vertical ocular misalignment in thyroid eye disease using an adjustable suture technique. J AAPOS. 2012;16:518–22.

    Article  PubMed  Google Scholar 

  66. Coats D, Paysse E, Plager D, Wallace D. Early strabismus surgery for thyroid ophthalmopathy. Ophthalmology. 1999;106:324–9.

    Article  CAS  PubMed  Google Scholar 

  67. Thomas SM, Cruz OA. Comparison of two different surgical techniques for the treatment of strabismus in dysthyroid ophthalmopathy. J AAPOS. 2007;11:258–61.

    Article  PubMed  Google Scholar 

  68. Lee YH, Oh SY, Hwang JM. Is 6 months of stable angle of strabismus enough to perform surgery in patients with strabismus related to thyroid ophthalmopathy? Br J Ophthalmol. 2010;94:955–6.

    Article  PubMed  Google Scholar 

  69. Rootman DB, Golan S, Pavlovich P, Rootman J. Postoperative changes in strabismus, ductions, exophthalmometry, and eyelid retraction after orbital decompression for thyroid orbitopathy. Ophthalmic Plast Reconstr Surg. 2017;33:289–93.

    Article  PubMed  Google Scholar 

  70. Zloto O, Ben Simon G, Didi Fabian I, Sagiv O, Huna-Baron R, Ben Zion I, et al. Association of orbital decompression and the characteristics of subsequent strabismus surgery in thyroid eye disease. Can J Ophthalmol. 2017;52:264–8.

    Article  PubMed  Google Scholar 

  71. Nardi M. Squint surgery in TED hints and fints, or why Graves’ patients are difficult patients. Orbit. 2009;28:245–50.

    CAS  PubMed  Google Scholar 

  72. Nunery WR, Nunery CW, Martin RT, Truong TV, Osborn DR. The risk of diplopia following orbital floor and medial wall decompression in subtypes of ophthalmic Graves’ disease. Ophthalmic Plast Reconstr Surg. 1997;13:153–60.

    Article  CAS  PubMed  Google Scholar 

  73. Fabian ID, Rosen N, Ben Simon GJ. Strabismus after inferior-medial wall orbital decompression in thyroid-related orbitopathy. Curr Eye Res. 2013;38:204–9.

    Article  PubMed  Google Scholar 

  74. Chang M, Baek S, Lee TS. Long-term outcomes of unilateral orbital fat decompression for thyroid eye disease. Graefes Arch Clin Exp Ophthalmol. 2013;251:935–9.

    Article  PubMed  Google Scholar 

  75. Prat MC, Braunstein AL, Glass LRD, Kazim M. Orbital fat decompression for thyroid eye disease: Retrospective case review and criteria for optimal case selection. Ophthal Plast Reconstr Surg. 2015;31:215–8.

    Article  PubMed  Google Scholar 

  76. Richter DF, Stoff A, Olivari N. Transpalpebral decompression of endocrine ophthalmopathy by intraorbital fat removal (Olivari technique): Experience and progression after more than 3000 operations over 20 years. Plast Reconstr Surg. 2007;120:109–23.

    Article  CAS  PubMed  Google Scholar 

  77. European Group on Graves’ Orbitopathy (EUGOGO), Mourits MP, Bijl H, Altea MA, et al. Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures. Br J Ophthalmol. 2009;93:1518–23.

    Article  Google Scholar 

  78. Kacker A, Kazim M, Murphy M, et al. “Balanced” orbital decompression for severe Graves’ orbitopathy: technique with treatment algorithm. Otolaryngol Head Neck Surg. 2003;182:228–35.

    Google Scholar 

  79. Sellari-Franceschini S, Berrettini S, Santoro A, et al. Orbital decompression in Graves’ ophthalmopathy by medial and lateral wall decompression. Otolaryngol Head Neck Surg. 2005;133:185–9.

    Article  PubMed  Google Scholar 

  80. de Souza S, Lima LC, Velarde LG, Vianna RN, Herzog NG. The effect of horizontal strabismus surgery on the vertical palpebral fissure width. J AAPOS. 2011;15:473–5.

    Article  Google Scholar 

  81. Fichter N, Krentz H, Guthoff RF. Functional and aesthetic outcome after bony lateral wall decompression with orbital rim removal and additional fat resection in Graves’ orbitopathy with regard to the configuration of the lateral canthal region. Orbit. 2013;32:239–46.

    Article  PubMed  Google Scholar 

  82. Lagreze WA, Gerling J, Staubach F. Changes of the 1383 lid fissure after surgery on horizontal extraocular muscles. Am J Ophthalmol. 2005;140:1145–6.

    Article  PubMed  Google Scholar 

  83. Ben Simon GJ, Mansury AM, Schwarcz RM, Lee S, McCann JD, et al. Simultaneous orbital decompression and correction of upper eyelid retraction versus staged procedures in thyroid-related orbitopathy. Ophthalmology. 2005;112:923–32.

    Article  PubMed  Google Scholar 

  84. Quaranta-Leoni FM, Di Marino M, Leonardi A, Verrilli S, Romeo R. Single-stage orbital decompression, strabismus and eyelid surgery in moderate to severe thyroid associated orbitopathy. Orbit. 2022;41:184–92.

    Article  PubMed  Google Scholar 

  85. Gomi CF, Yang S-W, Granet DB, et al. Change in proptosis following extraocular muscle surgery: effects of muscle recession in thyroidassociated orbitopathy. J AAPOS. 2007;4:377–80.

    Article  Google Scholar 

  86. Ponto KA, Hommel G, Pitz S, Elflein H, Pfeiffer N, Kahaly GJ. Quality of life in a German Graves orbitopathy population. Am J Ophthalmol. 2011;152:483–90.

    Article  PubMed  Google Scholar 

  87. Vishwanath M, Ansons A. Midoperative forced duction test as a guide to titrate the surgery for consecutive exotropia. Strabismus. 2009;17:41–4.

    Article  PubMed  Google Scholar 

  88. Kim S, Yang HK, Hwang JM. Surgical outcomes of unilateral recession and resection in intermittent exotropia according to forced duction test results. PLoS One. 2018;13:0200741.

    Google Scholar 

  89. Jung JH, Holmes JM. Quantitative intraoperative torsional forced duction test. Ophthalmology. 2015;122:1932–8.

    Article  PubMed  Google Scholar 

  90. Al Qahtani ES, Rootman J, Kersey J, Godoy F, Lyons CJ. Clinical pearls and management recommendations for strabismus due to thyroid orbitopathy. Middle East Afr J Ophthalmol. 2015;22:307–11.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Lyu IJ, Lee JY, Kong M, Park KA, Oh SY. Surgical responses of medial rectus muscle recession in thyroid eye disease-related esotropia. PLoS One. 2016;11:0146779.

    Article  Google Scholar 

  92. Nugent RA, Belkin RI, Neigel J, et al. Graves orbitopathy: correlation of CT and clinical findings. Radiology. 1990;177:675–82.

    Article  CAS  PubMed  Google Scholar 

  93. Dyer J. The oculorotary muscles in Graves’ disease. Trans Am Ophthalmol Soc. 1976;74:425–56.

    CAS  PubMed  PubMed Central  Google Scholar 

  94. Kushner BJ. Torsion and pattern strabismus: potential conflicts in treatment. JAMA Ophthalmol. 2013;131:190–3.

    Article  PubMed  Google Scholar 

  95. Dagi LR, Elliott AT, Roper-Hall G, Cruz OA. Thyroid eye disease: honing your skills to improve outcomes. J AAPOS. 2010;14:425–31.

    Article  PubMed  Google Scholar 

  96. Del Monte MA. 2001 an ocular odyssey: lessons learned from 25 years of surgical treatment for Graves eye disease. Am Orthopt J. 2002;52:40e57.

    Google Scholar 

  97. Kushner BJ. A surgical procedure to minimize lower-eyelid retraction with inferior rectus recession. Arch Ophthalmol. 1992;110:1011–4.

    Article  CAS  PubMed  Google Scholar 

  98. Akbari MR, Raygan F, Ameri A, Jafari A, Eshraghi B, Fard MA. Lower eyelid retractor lysis versus Lockwood advancement to minimize lower eyelid retraction resulting from inferior rectus muscle recession. J AAPOS. 2013;4:445–7.

    Article  Google Scholar 

  99. Weldy E, Kerr NC. Lateral rectus muscle resection following maximal recession of the medial rectus muscle in thyroid eye disease. J AAPOS. 2017;21:291–4.

    Article  PubMed  Google Scholar 

  100. Kim EY, Roper-Hall G, Cruz OA. Effectiveness of bilateral lateral rectus resection for residual esotropia in dysthyroid ophthalmopathy. Am J Ophthalmol. 2016;171:84–7.

    Article  PubMed  Google Scholar 

  101. Nicholson BP, De Alba M, Perry JD, Traboulsi EI. Efficacy of the intraoperative relaxed muscle positioning technique in thyroid eye disease and analysis of cases requiring reoperation. J AAPOS. 2011;15:321–5.

    Article  PubMed  Google Scholar 

  102. Cruz OA, Davitt BV. Bilateral inferior rectus muscle recession for correction of hypotropia in dysthyroid ophthalmopathy. J AAPOS. 1999;3:157–9.

    Article  CAS  PubMed  Google Scholar 

  103. Barker L, Mackenzie K, Adams GG, Hancox J. Long-term surgical outcomes for vertical deviations in thyroid eye disease. Strabismus. 2017;25:67–72.

    Article  PubMed  Google Scholar 

  104. Kushner BJ. An evaluation of the semiadjustable suture strabismus surgical procedure. J AAPOS. 2004;8:481–7.

    Article  PubMed  Google Scholar 

  105. Kerr NC. The role of thyroid eye disease and other factors in the overcorrection of hypotropia following unilateral adjustable suture recession of the inferior rectus (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2011;109:168–200.

    PubMed  PubMed Central  Google Scholar 

  106. Oeverhaus M, Fischer M, Hirche H, Schluter A, Esser J, Eckstein AK. Tendon elongation with bovine pericardium in patients with severe esotropia after decompression in Graves’ orbitopathy-efficacy and long-term stability. Strabismus. 2018;26:62–70.

    Article  PubMed  Google Scholar 

  107. Ozkan SB, Kir E, Culhaci N, Dayanir V. The effect of seprafilm on adhesions in strabismus surgery – an experimental study. J AAPOS. 2004;8:46–9.

    Article  PubMed  Google Scholar 

  108. Mora JS, Sprunger DT, Helveston EM, Evan AP. Intraoperative sponge 5-fluorouracil to reduce postoperative scarring in strabismus surgery. J AAPOS. 1997;1:92–7.

    Article  CAS  PubMed  Google Scholar 

  109. Minguini N, Monteiro de Carvalho KM, Akaishi PM, De Luca IM. Histologic effect of mitomycin C on strabismus surgery in the rabbit. Invest Ophthalmol Vis Sci. 2000;41:3399–401.

    CAS  PubMed  Google Scholar 

  110. Kassem RR, El-Mofty RMA-M. Amniotic membrane transplantation in strabismus surgery. Curr Eye Res. 2019;44:451–64.

    Article  PubMed  Google Scholar 

  111. Strube YNJ, Conte F, Faria C, Yiu S, Wright KW. Amniotic membrane transplantation for restrictive strabismus. Ophthalmology. 2011;118:1175–9.

    Article  PubMed  Google Scholar 

  112. Shorr N, Seiff SR. The four stages of surgical rehabilitation of the patient with dysthyroid ophthalmopathy. Ophthalmology. 1986;93:476–83.

    Article  CAS  PubMed  Google Scholar 

  113. Choi SW, Lee JY, Lew H. Customized orbital decompression surgery combined with eyelid surgery or strabismus surgery in mild to moderate thyroid-associated ophthalmopathy. Korean J Ophthalmol. 2016;30:1–9.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Dal Canto AJ, Crowe S, Perry JD, Traboulsi EI. Intraoperative relaxed muscle positioning technique for strabismus repair in thyroid eye disease. Ophthalmology. 2006;113:2324–30.

    Article  PubMed  Google Scholar 

  115. Peragallo JH, Velez FG, Demer JL, Pineles SL. Postoperative drift in patients with thyroid ophthalmopathy undergoing unilateral inferior rectus muscle recession. Strabismus. 2013;21:23–8.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Finn AP, Bleier B, Cestari DM, Kazlas MA, Dagi LR, Lefebvre DR, et al. A retrospective review of orbital decompression for thyroid orbitopathy with endoscopic preservation of the inferomedial orbital bone strut. Ophthal Plast Reconstr Surg. 2017;33:334–9.

    Article  PubMed  Google Scholar 

  117. Jimenez-Chobillon MA, Lopez-Oliver RD. Transnasal endoscopic approach in the treatment of Graves ophthalmopathy: the value of a medial periorbital strip. Eur Ann Otorhinolaryngol Head Neck Dis. 2010;127:97–103.

    Article  PubMed  Google Scholar 

  118. Michel O, Oberlander N, Neugebauer P, Neugebauer A, Rüssmann W. Follow-up of transnasal orbital decompression in severe Graves’ ophthalmopathy. Ophthalmology. 2001;108:400–4.

    Article  CAS  PubMed  Google Scholar 

  119. Vaidya A, Kakizaki H, Takahashi Y. Changes in horizontal strabismus after inferior rectus muscle recession with or without nasal transposition in thyroid eye disease: A retrospective, observational study. PLoS One. 2020;15:e0240019.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Tooley AA, Godfrey KJ, Kazim M. Evolution of thyroid eye disease decompression-dysthyroid optic neuropathy. Eye (Lond). 2019;33:206–11.

    Article  PubMed  Google Scholar 

  121. Oropesa S, Dunbar KE, Godfrey KJ, Callahan AB, Campbell AA, Kazim M. Predominant contribution of superior rectus–levator complex enlargement to optic neuropathy and inferior visual field defects in thyroid eye disease. Ophthal Plast Reconstr Surg. 2019;35:262–5.

    Article  PubMed  Google Scholar 

  122. Mocan MC, Ament C, Azar NF. The characteristics and surgical outcomes of medial rectus recessions in Graves’ ophthalmopathy. J Pediatr Ophthalmol Strabismus. 2007;44:93–100.

    Article  PubMed  Google Scholar 

  123. Ha SG, Kim SH. Initial postoperative alignment in strabismus related to thyroid eye disease. J Pediatr Ophthalmol Strabismus. 2021;58:23–7.

    Article  PubMed  Google Scholar 

  124. Jellema HM, Saeed P, Braaksma-Besselink Y, Schuit A, Kloos R, Mourits MP. Unilateral and bilateral medial rectus recession in Graves’ orbitopathy patients. Strabismus. 2014;22:182–7.

    Article  PubMed  Google Scholar 

  125. Scofield-Kaplan SM, Dunbar K, Stein G, Kazim M. improvement in both primary and eccentric ocular alignment after thyroid eye disease-strabismus surgery with tenon’s recession. Ophthalmic Plast Reconstr Surg. 2018;34:S85–9.

    Google Scholar 

  126. Pineles SL, Chang MY, Holmes JM, Kekunnaya R, Özkan SB, Velez FG. Innovative techniques for the treatment of adult strabismus. J AAPOS. 2019;23:132–9.

    Article  PubMed  Google Scholar 

  127. Thorisdottir RL, Blohmé J, Malmsjö M. Clinical evidence supporting the use of donor sclera as spacer material in complicated cases of strabismus surgery - retrospective evaluation of surgical results in 117 patients with thyroid-associated ophthalmopathy or congenital strabismus. Acta Ophthalmol. 2019;97:74–9.

    Article  PubMed  Google Scholar 

  128. Honglertnapakul W, Cavuoto KM, McKeown CA, Capó H. Surgical treatment of strabismus in thyroid eye disease: characteristics, dose-response, and outcomes. J AAPOS. 2020;24:72.e1–7.

    Article  PubMed  Google Scholar 

  129. De Hoog J, Stravers S, Kalmann R. Recession of the inferior rectus muscle in Graves’ orbitopathy. Eye (Lond). 2010;24:1011–7.

    Article  PubMed  Google Scholar 

  130. Chatzistefanou KI, Kushner BJ, Gentry LR. Magnetic resonance imaging of the arc of contact of extraocular muscles: Implications regarding the incidence of slipped muscles. J AAPOS. 2000;4:84–93.

    Article  CAS  PubMed  Google Scholar 

  131. Hudson HL, Feldon SE. Late overcorrection of hypotropia in Graves ophthalmopathy. Predictive factors. Ophthalmology. 1992;99:356–60.

    Article  CAS  PubMed  Google Scholar 

  132. Kushner BJ. Management of diplopia limited to down gaze. Arch Ophthalmol. 1995;113:1426–30.

    Article  CAS  PubMed  Google Scholar 

  133. Akbari MR, Raygan F, Ameri A, Jafari A, Eshraghi B, Fard MA. Lower eyelid retractor lysis versus Lockwood advancement to minimize lower eyelid retraction resulting from inferior rectus muscle recession. J AAPOS. 2013;17:445–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

    Gustavo Savino

  2. Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Austria

    Andrea Papp

  3. Oftalmoplastica Roma, Rome, Italy

    Francesco M. Quaranta Leoni

Authors
  1. Gustavo Savino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Papp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco M. Quaranta Leoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gustavo Savino .

Editor information

Editors and Affiliations

  1. Oftalmoplastica Roma, Roma, Italy

    Francesco M. Quaranta Leoni

  2. Moorfields Eye Hospital, London, UK

    David H Verity

  3. Rotterdam Eye Hospital, Rotterdam, The Netherlands

    Dion Paridaens

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Savino, G., Papp, A., Quaranta Leoni, F.M. (2024). Strabismus in Thyroid-Associated Orbitopathy. In: Quaranta Leoni, F.M., Verity, D.H., Paridaens, D. (eds) Oculoplastic, Lacrimal and Orbital Surgery. Springer, Cham. https://doi.org/10.1007/978-3-031-39638-0_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-39638-0_37

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-39637-3

  • Online ISBN: 978-3-031-39638-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation